From fundamental new understandings of the cell published in Nature to landmark clinical trials in the New England Journal of Medicine and cross-disciplinary collaborations in Science Translational Medicine, investigators throughout our institution have advanced new knowledge that is already transforming their diverse fields.
The world’s smallest wearable device has been developed by Northwestern scientists, to measure exposure to light across multiple wavelengths.
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
The ventral striatum, a small part of the brain’s basal ganglia, directs behavior by assigning a reward dimension to everyday items, according to a recent study.
A recent study found that stability of chromatin structures across DNA replication requires cooperation between a histone chaperone and DNA replication machinery; a mechanism of epigenetic inheritance.
Adults who develop high blood pressure before the age of 40 are at a significantly higher risk for cardiovascular events later in life, according to a Northwestern Medicine study.
Northwestern Medicine scientists have discovered that amacrine cells produce nitric oxide, a neuromodulator that regulates blood dilation, in a recently published study.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.